About Us Products in Development Patients & Caregivers Investors & Media Partnering
Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

Sunesis In The News

Oct 12 2020
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Sep 03 2020
Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Sep 02 2020
Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock Split

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.

With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives!



Want to learn more about
Chronic Lymphocytic Leukemia?
Please visit:
Know AML - World Awareness Day 21 April
CLLS is a patient–centric, physician–curated nonprofit organization focused on patient education, support and research dedicated to addressing the unmet needs of the CLL (chronic lymphocytic leukemia) community.
© 2020 Sunesis Pharmaceuticals, Inc. - SVR-WEB00-SYM
Contact Us | Careers | Terms of Use | Site Map